Predictors of Prognosis in IBD Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSeoul National University Bundang Hospital
About this trial
A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease
Eligibility criteria
Qualifiers
control group: Patients who do not have colitis, cancer, and advanced polyp (the number of polyps ≥ 3, the size of polyps ≥ 1cm, high-grade adenoma, villous adenoma)
TNF-α inhibitor-naive IBD group: IBD patients who do not have a history of TNF-α inhibitor treatment
TNF-α inhibitor-treated IBD group: IBD patients who are treated with TNF-α inhibitor
Disqualifiers
Age under 18 years
Patients who were treated with antibiotics or probiotics within the last 3 months
Trial design
Treatments tested in this trial
- Endoscopic biopsy
Treatment groups
100 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov